UnknownPhase 2NCT05156450

TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone in Metastatic Castration-Resistant Prostate Cancer

Studying Cap myopathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
West China Hospital
Principal Investigator
Hao Zeng
West China Hospital
Intervention
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone(drug)
Enrollment
30 enrolled
Eligibility
18-80 years · MALE
Timeline
2022 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05156450 on ClinicalTrials.gov

Other trials for Cap myopathy

Additional recruiting or active studies for the same condition.

See all trials for Cap myopathy →

← Back to all trials